6797 Stock Overview
Designs and manufactures products for nucleic acid purification.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Taiwan Advanced Nanotech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$21.50 |
| 52 Week High | NT$44.40 |
| 52 Week Low | NT$20.80 |
| Beta | 0.54 |
| 11 Month Change | 0.47% |
| 3 Month Change | -7.73% |
| 1 Year Change | -33.33% |
| 33 Year Change | -79.89% |
| 5 Year Change | n/a |
| Change since IPO | -91.38% |
Recent News & Updates
Shareholder Returns
| 6797 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -0.7% | -1.5% | 2.3% |
| 1Y | -33.3% | 6.1% | 37.7% |
Return vs Industry: 6797 underperformed the TW Medical Equipment industry which returned 6.1% over the past year.
Return vs Market: 6797 underperformed the TW Market which returned 37.7% over the past year.
Price Volatility
| 6797 volatility | |
|---|---|
| 6797 Average Weekly Movement | 3.9% |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6797 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6797's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Raman Chien | www.tanbead.com |
Taiwan Advanced Nanotech Inc. designs and manufactures products for nucleic acid purification. The company’s products include reagent kits, which are used in DNA/RNA extractions from samples of blood, cell, tissue, plant, bacteria, virus, etc.; magnetic nanoparticles, including super-paramagnetic iron oxide and ultra small super-paramagnetic iron oxide for molecular biology applications; automated extraction instruments; and consumables, such as spin tips and deep well plates. It offers its products to disease control centers, testing institutions, hospitals, and other related facilities.
Taiwan Advanced Nanotech Inc. Fundamentals Summary
| 6797 fundamental statistics | |
|---|---|
| Market cap | NT$660.74m |
| Earnings (TTM) | -NT$238.49m |
| Revenue (TTM) | NT$199.70m |
3.3x
P/S Ratio-2.8x
P/E RatioIs 6797 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6797 income statement (TTM) | |
|---|---|
| Revenue | NT$199.70m |
| Cost of Revenue | NT$250.36m |
| Gross Profit | -NT$50.67m |
| Other Expenses | NT$187.83m |
| Earnings | -NT$238.49m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.76 |
| Gross Margin | -25.37% |
| Net Profit Margin | -119.43% |
| Debt/Equity Ratio | 14.7% |
How did 6797 perform over the long term?
See historical performance and comparison